摘要:
sci-hub.se 参考文章(87)
Michael S Gordon, Molly L Young, Martin S Tallman, Larry D Cripe, John M Bennett, Elisabeth Paietta, Walter Longo, Henry Gerad, Joseph Mazza, Jacob M Rowe, Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995. Leukemia Research. ,vol. 24, pp. 871- 875 ,(2000) , 10.1016/S0145-2126(00)00043-6
Shimon Slavin, Arnon Nagler, Ella Naparstek, Yossi Kapelushnik, Memet Aker, Gabriel Cividalli, Gabor Varadi, Mark Kirschbaum, Aliza Ackerstein, Simcha Samuel, Avraham Amar, Chaim Brautbar, Ofira Ben-Tal, Amiram Eldor, Reuven Or, Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases Blood. ,vol. 91, pp. 756- 763 ,(1998) , 10.1182/BLOOD.V91.3.756.756_756_763
MJ Keating, H Kantarjian, M Talpaz, J Redman, C Koller, B Barlogie, W Velasquez, W Plunkett, EJ Freireich, KB McCredie, Fludarabine: a new agent with major activity against chronic lymphocytic leukemia Blood. ,vol. 74, pp. 19- 25 ,(1989) , 10.1182/BLOOD.V74.1.19.19
Alan Saven, Carol Burian, James A. Koziol, Lawrence D. Piro, Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment Blood. ,vol. 92, pp. 1918- 1926 ,(1998) , 10.1182/BLOOD.V92.6.1918
Steven M. Kornblau, Elihu Estey, Jorge Cortes-Franco, Neurotoxicity associated with fludarabine and cytosine arabinoside chemotherapy for acute leukemia and myelodysplasia. Leukemia. ,vol. 7, pp. 378- 383 ,(1993)
M.J. Keating, S. O’Brien, S. Lerner, C. Koller, M. Beran, L.E. Robertson, E. J Freireich, E. Estey, H. Kantarjian, Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood. ,vol. 92, pp. 1165- 1171 ,(1998) , 10.1182/BLOOD.V92.4.1165
Balcerzak Sp, Kopecky Kj, Hutton Jj, Grever Mr, Greenberg Br, Talley R, Von Hoff Dd, Coltman Ca, Files Jc, Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia. Nouvelle revue française d'hématologie. ,vol. 30, pp. 457- 459 ,(1988)
DA Carson, DB Wasson, R Taetle, A Yu, Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes Blood. ,vol. 62, pp. 737- 743 ,(1983) , 10.1182/BLOOD.V62.4.737.737
JF Seymour, R Kurzrock, EJ Freireich, EH Estey, 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia Blood. ,vol. 83, pp. 2906- 2911 ,(1994) , 10.1182/BLOOD.V83.10.2906.2906
H. M. Kantarjian, C. A. Koller, V. Gandhi, S. O'Brien, W. Plunkett, E. Estey, H. M. Andreeff, M. Beran, S. M. Kornblau, Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults. Leukemia. ,vol. 10, pp. 1563- 1569 ,(1996)